Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,330 total articles
Cryoport is executing infrastructure and product rollouts that materially lower per-shipment costs and expand addressable capacity for cell and gene therapy logistics. With a market cap below $400M, improving margins, positive ROE/ROA, and a path to near-term breakeven, the stock offers a favorable risk-reward for a position trade. Entry at $7.90, …
Janus International (JBI) looks increasingly attractive at current levels. The stock trades near its 52-week low while the company generates strong free cash flow, carries meaningful cash on the balance sheet, and sits at valuation multiples that imply recovery potential. This trade idea outlines an actionable long with entry, stop, and target alon…
Shake Shack reported 22% revenue growth in Q4 and is guiding to meaningful unit expansion in 2026 while free cash flow is beginning to show positive momentum. At $83.62, the stock trades at an EV/sales of ~2.2 and a lofty P/E near 70 but with improving operating leverage and $1.47B of cash that supports share-price optionality. This trade idea lays…
Universal Music Group appears to have priced in a tougher near-term macro and regulatory backdrop, while the core music-as-a-service business continues to benefit from durable streaming demand, recurring royalty economics and higher-margin publishing and sync opportunities. This trade sets a clear entry, stop and target with a long-term horizon and…
Adyen looks attractive after a period of multiple compression. The business still owns a best-in-class global payments platform, with durable monetization and exposure to secular e-commerce and omnichannel payments growth. This trade outlines a mid-term (45 trading days) swing long with a clear entry, stop and target, plus catalysts that could re-r…
Carlyle Secured Lending appears to have priced a lower, reset dividend into the market. That creates a tactical long opportunity where upside is driven by earnings/NAV verification and improved market sentiment. This trade uses a precise entry, stop and two-tier target plan over a 45- to 180-day horizon.
Exxon Mobil looks set to continue benefiting from a favorable mix of stronger commodity pricing, resilient downstream margins and incremental upstream volumes. This trade idea sizes a mid-term long with clear entry, target and stop levels tied to expected cash-flow resilience and near-term catalysts.
Badger Meter has reset materially from 2025 highs and now offers a buyable mix of recurring software revenue growth, improving margins and a fortress balance sheet. Valuation has come in to a reasonable multiple for a mid-teens growth story; this note lays out an actionable long-term trade with entry, stop and target and the catalysts and risks tha…
Clorox (CLX) offers a sensible trading opportunity for income-oriented investors able to tolerate a medium level of company-specific risk. At roughly $102 per share, the stock yields near 4.8%, trades at a mid-teens P/E, and is sitting close to its 52-week low after a margin squeeze and a retailer inventory reset shaved expected sales and EPS. The …
Uber is getting dinged by headlines around autonomous partnerships and macro noise, but fundamentals - $9.09B free cash flow, a $143.9B market cap, and healthy margins - suggest the stock is mispriced for a 11-45 trading day rebound. This trade idea lays out an entry, stop, targets, catalysts and the specific risks that could derail the setup.
Corcept Therapeutics popped after the FDA approved Lifyorli for platinum-resistant ovarian, fallopian tube and primary peritoneal cancer. The regulatory green light materially reduces binary regulatory risk and creates a clear commercial catalyst. We upgrade to a buy and lay out an actionable trade: entry $38.12, stop $31.00, primary target $60.00 …
Castle Biosciences is set up for a meaningful re-rating as prospective validation of its DecisionDx-Melanoma i31-SLNB test reduces clinical uncertainty for sentinel lymph node management. With a $699.6M market cap, low leverage, positive free cash flow, and oversold technicals, we outline a mid-term trade to capture upside while keeping strict risk…
NetApp is trading at a mid-teens P/E with healthy free cash flow and a dividend, while industry tailwinds (hybrid cloud, AI workloads, SAN refresh cycles) support rising billings. Technicals show bullish momentum and short interest remains elevated, supplying squeeze potential. We recommend a mid-term swing buy with a clear entry, stop and target t…
Block announces a targeted 40% reduction in its AI workforce. We view this as a decisive margin-recovery lever that could unlock meaningful operating-margin upside and multiple expansion. This trade plan targets a rebound driven by improved profitability rather than a pure top-line rerate.
Liberty Media's Formula One vehicle looks vulnerable to a near-term pullback despite durable long-term fundamentals. Short a tactical 10-trading-day trade around $76.94 with a tight stop, then consider accumulating for a 180-trading-day recovery if the market confirms lower levels.
SS Innovations (SSII) is a sub-$1B surgical robotics name showing clear commercial progress: Q2 2025 revenue doubled to $10.0M, system installations are increasing and the company is professionalizing its finance and operations team. That combination — real top-line growth, improving governance, and an AI-enabled platform — supports a long idea wit…
Indivior reported a FY25 beat and reiterated a clear playbook: grow SUBLOCADE penetration while reshaping the balance sheet. With guidance for 2026 calling for $1.125–$1.195B in revenue and management upsizing a $450M convertible issue to repay debt and buy back stock, the risk/reward favors a long over the next 180 trading days. Technicals show ne…
AT&T’s pivot to fiber and fixed broadband is entering a phase where scale and margin conversion can finally outpace legacy wireless churn. This trade idea sizes a tactical long around an anticipated re-acceleration in fiber net adds and steady free-cash-flow improvement, with strict risk controls.
Marvell is showing clearer top-line momentum driven by AI and networking design wins. Management's guidance and recent quarter growth point to accelerating data-center revenue, while valuation and cash flow leave room for upside. This trade idea lays out an entry at the intraday level, a protective stop, and targets across a mid-to-long-term horizo…
CVR Energy (CVI) is a cash-flow leveraged refiner with a three-legged business - petroleum refining, renewables and nitrogen fertilizer - trading at a modest EV/EBITDA and offering a clear swing trade: enter near $35.00, stop $31.00, target $42.00 over a 45-trading-day horizon if macro spreads hold.
Meta is a high-quality franchise trading well below its highs after a volatile stretch for growth stocks. I want to be long, but only on a deeper pullback. Buying at $450 brings valuation to ~19x earnings and improves the risk-reward materially. This trade idea outlines the entry, stop, target, catalysts, and what would change my mind.
Simply Good Foods (SMPL) has slid to the low teens while still generating healthy free cash flow and trading at single-digit EV/FCF multiples. With solid liquidity, well-known brands (Atkins, Quest), and several near-term catalysts, the risk/reward looks asymmetric for a mid-term swing trade. Entry $14.40, stop $13.50, target $18.00 — horizon: mid …
Advanced Micro Devices has the cash flow, balance sheet and product lineup to benefit from another leg of AI infrastructure spending. Recent technical consolidation and institutional interest create a favorable entry window for a long-term trade toward $260, with a disciplined $180 stop to control downside.
Vista Energy (VIST) is trading near its 52-week high after a stretch of strong production growth and improving margins. With a market cap of roughly $7.44B and a PE of ~10.5, the stock offers oil-price leverage and secular upside from Vaca Muerta and Mexican production. This trade idea favors a buy-on-pullback toward $75 with a $95 target over the …
Lockheed Martin is trading off recent highs but still carries a $194B backlog, steady free cash flow and structural exposure to accelerating space and missile-defense budgets. This idea argues for a long entry at $615.84 with a $843 target over the next 180 trading days, driven by contract conversion, higher government spending and improving margin…
